![Mathematical modeling of the early modeled CA-125 longitudinal kinetics (KELIM-PARP) as a pragmatic indicator of rucaparib efficacy in patients with recurrent ovarian carcinoma in ARIEL2 & STUDY 10 - eBioMedicine Mathematical modeling of the early modeled CA-125 longitudinal kinetics (KELIM-PARP) as a pragmatic indicator of rucaparib efficacy in patients with recurrent ovarian carcinoma in ARIEL2 & STUDY 10 - eBioMedicine](https://www.thelancet.com/cms/asset/362297e3-e465-4949-9cd3-f4e0a43c2525/gr2.jpg)
Mathematical modeling of the early modeled CA-125 longitudinal kinetics (KELIM-PARP) as a pragmatic indicator of rucaparib efficacy in patients with recurrent ovarian carcinoma in ARIEL2 & STUDY 10 - eBioMedicine
β-Sheet Richness of the Circulating Tumor-Derived Extracellular Vesicles for Noninvasive Pancreatic Cancer Screening | ACS Sensors
![Mathematical modeling of the early modeled CA-125 longitudinal kinetics (KELIM-PARP) as a pragmatic indicator of rucaparib efficacy in patients with recurrent ovarian carcinoma in ARIEL2 & STUDY 10 - eBioMedicine Mathematical modeling of the early modeled CA-125 longitudinal kinetics (KELIM-PARP) as a pragmatic indicator of rucaparib efficacy in patients with recurrent ovarian carcinoma in ARIEL2 & STUDY 10 - eBioMedicine](https://www.thelancet.com/cms/attachment/250521d3-eb08-4bf4-a8ac-599b87b859e5/gr1.jpg)
Mathematical modeling of the early modeled CA-125 longitudinal kinetics (KELIM-PARP) as a pragmatic indicator of rucaparib efficacy in patients with recurrent ovarian carcinoma in ARIEL2 & STUDY 10 - eBioMedicine
![Diagnostics | Free Full-Text | The Potential Role of MUC16 (CA125) Biomarker in Lung Cancer: A Magic Biomarker but with Adversity Diagnostics | Free Full-Text | The Potential Role of MUC16 (CA125) Biomarker in Lung Cancer: A Magic Biomarker but with Adversity](https://pub.mdpi-res.com/diagnostics/diagnostics-12-02985/article_deploy/html/images/diagnostics-12-02985-g001.png?1669713043)
Diagnostics | Free Full-Text | The Potential Role of MUC16 (CA125) Biomarker in Lung Cancer: A Magic Biomarker but with Adversity
![Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.2021210005/asset/images/medium/rg.2021210005.va.gif)
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
![Frontiers | Stratification of ovarian cancer borderline from high-grade serous carcinoma patients by quantitative serum NMR spectroscopy of metabolites, lipoproteins, and inflammatory markers Frontiers | Stratification of ovarian cancer borderline from high-grade serous carcinoma patients by quantitative serum NMR spectroscopy of metabolites, lipoproteins, and inflammatory markers](https://www.frontiersin.org/files/Articles/1158330/fmolb-10-1158330-HTML-r2/image_m/fmolb-10-1158330-g001.jpg)
Frontiers | Stratification of ovarian cancer borderline from high-grade serous carcinoma patients by quantitative serum NMR spectroscopy of metabolites, lipoproteins, and inflammatory markers
![Extra-ordinary High Cancer antigen 125 (CA-125) level in a 41 year-old patient with adenomyosis – ISGE Extra-ordinary High Cancer antigen 125 (CA-125) level in a 41 year-old patient with adenomyosis – ISGE](https://www.isge.org/wp-content/uploads/2021/10/TheTrocar-Vol2-Iss3_3_featured.jpg)
Extra-ordinary High Cancer antigen 125 (CA-125) level in a 41 year-old patient with adenomyosis – ISGE
![Diagnostics | Free Full-Text | Ultrasound Monitoring of Extant Adnexal Masses in the Era of Type 1 and Type 2 Ovarian Cancers: Lessons Learned From Ovarian Cancer Screening Trials Diagnostics | Free Full-Text | Ultrasound Monitoring of Extant Adnexal Masses in the Era of Type 1 and Type 2 Ovarian Cancers: Lessons Learned From Ovarian Cancer Screening Trials](https://pub.mdpi-res.com/diagnostics/diagnostics-07-00025/article_deploy/html/images/diagnostics-07-00025-ag.png?1569324877)
Diagnostics | Free Full-Text | Ultrasound Monitoring of Extant Adnexal Masses in the Era of Type 1 and Type 2 Ovarian Cancers: Lessons Learned From Ovarian Cancer Screening Trials
![Frontiers | High Serum Carbohydrate Antigen (CA) 125 Level Is Associated With Poor Prognosis in Patients With Light-Chain Cardiac Amyloidosis Frontiers | High Serum Carbohydrate Antigen (CA) 125 Level Is Associated With Poor Prognosis in Patients With Light-Chain Cardiac Amyloidosis](https://www.frontiersin.org/files/MyHome%20Article%20Library/692083/692083_Thumb_400.jpg)
Frontiers | High Serum Carbohydrate Antigen (CA) 125 Level Is Associated With Poor Prognosis in Patients With Light-Chain Cardiac Amyloidosis
![Value of cancer antigen 125 for diagnosis of pleural endometriosis in females with recurrent pneumothorax | European Respiratory Society Value of cancer antigen 125 for diagnosis of pleural endometriosis in females with recurrent pneumothorax | European Respiratory Society](https://erj.ersjournals.com/content/erj/31/1/140/F1.large.jpg)
Value of cancer antigen 125 for diagnosis of pleural endometriosis in females with recurrent pneumothorax | European Respiratory Society
![Prognostic relevance of high pretreatment CA125 levels in primary serous ovarian cancer Corrigendum in /10.3892/mco.2021.2247 Prognostic relevance of high pretreatment CA125 levels in primary serous ovarian cancer Corrigendum in /10.3892/mco.2021.2247](https://www.spandidos-publications.com/article_images/mco/14/1/mco-14-01-02170-g00.jpg)
Prognostic relevance of high pretreatment CA125 levels in primary serous ovarian cancer Corrigendum in /10.3892/mco.2021.2247
![Serum CA 125 is of clinical value in the staging and follow‐up of patients with non‐hodgkin's lymphoma - Lazzarino - 1998 - Cancer - Wiley Online Library Serum CA 125 is of clinical value in the staging and follow‐up of patients with non‐hodgkin's lymphoma - Lazzarino - 1998 - Cancer - Wiley Online Library](https://acsjournals.onlinelibrary.wiley.com/cms/asset/bb9bb199-b653-47b7-8993-12e910629806/mfig001.jpg)
Serum CA 125 is of clinical value in the staging and follow‐up of patients with non‐hodgkin's lymphoma - Lazzarino - 1998 - Cancer - Wiley Online Library
![Serum CA 125 level as a predictor of peritoneal dissemination in patients with gastric carcinoma - Nakata - 1998 - Cancer - Wiley Online Library Serum CA 125 level as a predictor of peritoneal dissemination in patients with gastric carcinoma - Nakata - 1998 - Cancer - Wiley Online Library](https://acsjournals.onlinelibrary.wiley.com/cms/asset/df3ebd58-d005-4607-a9bb-c18472ed6f9e/mfig001.jpg)
Serum CA 125 level as a predictor of peritoneal dissemination in patients with gastric carcinoma - Nakata - 1998 - Cancer - Wiley Online Library
![Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response | Diagnostic Pathology | Full Text Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response | Diagnostic Pathology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1746-1596-8-11/MediaObjects/13000_2012_Article_730_Fig1_HTML.jpg)
Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response | Diagnostic Pathology | Full Text
Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer | PLOS ONE
![Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature | Journal of Ovarian Research | Full Text Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature | Journal of Ovarian Research | Full Text](https://media.springernature.com/w200/springer-static/cover/journal/13048.jpg)
Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature | Journal of Ovarian Research | Full Text
![Cancers | Free Full-Text | Duration of Reduced CA19-9 Levels Is a Better Prognostic Factor Than Its Rate of Reduction for Unresectable Locally Advanced Pancreatic Cancer Cancers | Free Full-Text | Duration of Reduced CA19-9 Levels Is a Better Prognostic Factor Than Its Rate of Reduction for Unresectable Locally Advanced Pancreatic Cancer](https://pub.mdpi-res.com/cancers/cancers-13-04224/article_deploy/html/images/cancers-13-04224-g001-550.jpg?1629630402)